1-4 of 4
Carlo Croce
Close
Sort by
Journal Articles

MiRNA-29b Targets MCL-1 and Is Down-Regulated in Chemotherapy-Resistant Acute Myeloid Leukemia (AML).

Ramiro Garzon, Flavia Pichiorri, Guido Marcucci, Steve Kornblau, Michael Andreeff, Carlo Croce
Journal: Blood
Blood (2007) 110 (11): 717.
https://doi.org/10.1182/blood.V110.11.717.717
Published: 2007
Journal Articles

Elevated HIF-1α Levels in CLL B Cells May Explain Their Autocrine VEGF Secretion.

Yean K. Lee, Tait Shanafelt, MD, Denise Chan, Amato Giaccia, Debabrata Mukhopadhyay, PhD, Cristian Taccioli, George Calin, Carlo Croce, MD, Neil E. Kay, MD
Journal: Blood
Blood (2006) 108 (11): 583.
https://doi.org/10.1182/blood.V108.11.583.583
Published: 2006
Journal Articles

Gene Expression Profiling Identifies Similar CD4 + and CD8 + T Cell Defects in TCL1 Transgenic Mice after Development of CLL to Those Observed in Patients with CLL.

Vassiliki Rizouli, MD, David Zahrieh, MS, Gullu Gorgun, PhD, Tobias A.W. Holderried, Carlo Croce, MD, John G. Gribben, MD, DSc
Journal: Blood
Blood (2004) 104 (11): 180.
https://doi.org/10.1182/blood.V104.11.180.180
Published: 2004
Journal Articles

Cytogenetic Profile of Lymphoma of Follicle Mantle Lineage: Correlation With Clinicobiologic Features

Antonio Cuneo, Renato Bigoni, Gian Matteo Rigolin, Maria Grazia Roberti, Antonella Bardi, Nadia Piva, Raffaella Milani, Florencia Bullrich, Maria Luisa Veronese, Carlo Croce, Françoise Birg, Hartmut Döhner, Anne Hagemeijer, Gianluigi Castoldi
Journal: Blood
Blood (1999) 93 (4): 1372–1380.
https://doi.org/10.1182/blood.V93.4.1372
Published: 1999